Log In
BCIQ
Print this Print this
 

JAK2 MutaQuant

  Manage Alerts
Collapse Summary General Information
Company Qiagen N.V.
DescriptionKit for quantification of the janus kinase-2 (JAK-2) V617F allele in genomic DNA
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationHematology, Diagnostic
Indication DetailsDiagnose myeloproliferative disorders (MPD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today